CHICAGO and NEW YORK, Oct. 17, 2017 -- R1 RCM Inc. (NASDAQ:RCM), a leader in revenue cycle management and physician advisory services for healthcare providers, announced today a strategic partnership with Phreesia, a leading provider of patient intake management software, designed to transform the patient and provider experience, standardizing patient access and reducing administrative waste.
Through the partnership, R1 and Phreesia have created a unique offering that leverages R1’s distinctive operating model and Phreesia’s strength in patient self-service technology to provide a seamless front-end experience for patients across both ambulatory and inpatient settings.
“R1 is committed to the patient experience across all settings of care and payment models,” said Joe Flanagan, President and Chief Executive Officer of R1. “This partnership with Phreesia strengthens our front-end processes so providers can focus on patient care.”
The deal comes at a time when healthcare is becoming increasingly complex, patient financial responsibility is growing steadily, and large health systems are looking for ways to intake patients more efficiently and consistently.
“This partnership gives us the opportunity to provide a common and meaningful patient experience across our system,” said Tony Speranzo, Chief Financial Officer of Ascension. “It brings our acute-care partner and our valued partner in ambulatory care together to modernize patient access, and that aligns perfectly with our mission to become ‘One Ascension.’”
The new offering includes Phreesia’s patient-centric intake management features, including self-service automation, flexible payment options and mobile pre-registration capability.
“We’re so glad to be collaborating with R1 on this comprehensive offering,” said Chaim Indig, Chief Executive Officer of Phreesia. “R1 and Phreesia will continue to empower healthcare organizations by removing the administrative burdens that can stand in the way of high-quality care and a great patient experience.”
About R1 RCM Inc.
R1 serves as the one revenue cycle management partner for select hospitals and healthcare systems regardless of their payment models, partner engagement structures, or settings of care. The Company uses a proven operating model based on the R1 Performance StackSM designed to fit seamlessly into any healthcare organization’s infrastructure and to enhance the patient experience, improve provider economics, and provide revenue predictability. To learn more, visit r1rcm.com.
About Phreesia
Phreesia’s software gives healthcare organizations a suite of applications to manage the patient intake process. Our innovative platform engages patients in their care and provides a modern, consistent experience, while enabling our clients to maximize profitability, optimize their staffing and enhance clinical care. To find out how Phreesia can give your organization the capacity for more, visit phreesia.com.
Contacts
R1 Investor Relations:
Atif Rahim
312.324.5476
[email protected]
R1 Media Relations:
Deborah Lacy
650.814.7125
[email protected]
Phreesia:
Maureen McKinney
212.457.0257
[email protected]


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Washington Post Publisher Will Lewis Steps Down After Layoffs
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



